Expert Interviews
Expert Interviews
Christopher Kane, MDProstate Cancer | June 20, 2024
Dr. Kane shares insights into his career trajectory, highlighting moments that led him to specialize and leading in urology.
Read More
Roger Li, MDNon-Muscle Invasive Urothelial Carcinoma | May 28, 2024
Dr. Li rationalizes the design and potential impact of the MoonRISe-1 study for intermediate-risk NMIBC.
Jennifer Miles-Thomas, MD, FPMRSAUA 2024 | April 30, 2024
Dr. Miles-Thomas shares the challenges of female urology and her vision for her tenure as AUA treasurer.
Daniel Spratt, MDLocalized | April 17, 2024
Dr. Spratt ponders the evolving integration of RT with systemic treatments, challenges in counseling patients, and more.
Julian Chavarriaga, MDTesticular, Penile, and Rare Malignancies | April 12, 2024
Dr. Julian Chavarriaga describes his study on using miRNA as a liquid biomarker to detect malignancy in testicular masses.
Leonard Gomella, MD, FACSProstate Cancer Diagnostics | April 10, 2024
Dr. Gomella tells his journey to becoming a urologist, the importance of multidisciplinary care, and challenges in the field.
Shilpa Gupta, MDProstate Cancer | April 5, 2024
Dr. Gupta traces the trajectory of her career and describes her commitment to advancing the field through innovative trials.
James Sylora, MDLocalized | April 3, 2024
Dr. James Sylora shares his career, patient care, and vision for surgical and therapy advancements in community urology.
David Ambinder, MDProstate Cancer | March 29, 2024
Drs. Ambinder and Elsamra explore robotic surgery, including its applicability, patient benefits, and evolving role.
Gary Kirsh, MDProstate Cancer | March 22, 2024
Dr. Kirsh discusses his distinguished career and the evolution of urology practice in the United States.
Shuanzeng Wei, MD, PhDnccRCC | March 12, 2024
Dr. Wei helped uncover genetic, transcriptional, and immune differences in TFE3-rearranged RCC versus papillary, ccRCC.
Petros Grivas, MD, PhDUrothelial Carcinoma | March 4, 2024
Dr. Grivas shares insights into his career trajectory, driven by a passion to revolutionize the care of patients with UC.
Ariana L. Smith, MDSUO 2023 | December 20, 2023
Drs. Smith and Wallis shed light on how urologists can reduce risks and improve the well-being of their female patients.
Mark T. Fleming, MDProstate Cancer | October 18, 2023
Dr. Fleming details his early-phase clinical trial work that has had the largest impact on patients with GU malignancies.
Peter C. Black, MDNon-Muscle Invasive Urothelial Carcinoma | September 29, 2023
Dr. Black shares the basis for testing atezolizumab in BCG-unresponsive NMIBC as well as the implications of SWOG S1605.
Hans Hammers, MD, PhDRenal Cell Carcinoma | September 8, 2023
Dr. Hammers discusses the kidney clinical trials he has led and shares his perspectives on novel IO and targeted therapies.
Guru P. Sonpavde, MDMuscle Invasive Urothelial Carcinoma | August 31, 2023
Dr. Sonpavde expounds on the current state and momentum of research efforts to advance treatment strategies in MIBC.
Arlene O. Siefker-Radtke, MDAdvanced Urothelial Carcinoma | July 12, 2023
Dr. Siefker-Radtke shares the novel targeted therapies for bladder cancer and how they are assessed in combinations.
Pavlos Msaouel, MD, PhDRenal Cell Carcinoma | August 23, 2023
Dr. Msaouel shares his journey to becoming a world expert in RMC and the clinical trial work he led to improve outcomes.
Katherine Virgo, PhD, MBAExpert Interviews | May 3, 2023
Katherine Virgo, PhD, MBA, provided insight into ASCO's updated guideline for the management of metastatic prostate cancer.